StonvexLoading…
StonvexStonvexStonvexCore line items from AGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $114.20M | $103.46M | $156.31M | $98.02M |
Operating Income | $-20.17M | $-120.47M | $-159.55M | $-179.43M |
Net Income | $-3.08M | $-232.27M | $-257.44M | $-230.66M |
EPS (Diluted) | $0.00 | $-10.59 | $-13.75 | $-15.64 |
Total Assets | $226.80M | $226.27M | $313.91M | $413.56M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.00M | $40.44M | $76.11M | $178.67M |
Free Cash Flow OCF − CapEx | $-77.20M | $-158.89M | $-234.16M | $-228.44M |
Shares Outstanding | 35.32M | 23.63M | 17.89M | 14.09M |